<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="acrv-20260522.xsd" xlink:type="simple"/>
    <context id="C_8f59b5fa-b449-4e1c-9db0-df5ca7e5b321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001781174</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_8f59b5fa-b449-4e1c-9db0-df5ca7e5b321"
      id="F_f79b060f-40ba-4607-bf0e-7da5e3437e0c">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_8f59b5fa-b449-4e1c-9db0-df5ca7e5b321"
      id="F_2a36db6e-8ab2-4964-b2fa-d0f40acb0fd5">0001781174</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_8f59b5fa-b449-4e1c-9db0-df5ca7e5b321"
      id="F_d0570532-fbba-4a9a-802d-5e708660adc6">DEFA14A</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="C_8f59b5fa-b449-4e1c-9db0-df5ca7e5b321"
      id="F_c4298c00-9446-4311-97aa-d45b5489f6be">Acrivon Therapeutics, Inc.</dei:EntityRegistrantName>
</xbrl>
